My opinion is that this will go the same way as savient. Go it alone you will never have competitive formulary status. Quarterly cash burn is insane in relation to sales growth.
They have been trying to sell this company from day 1. The drug is a me too dog with fleas. Nobody wants to buy this sinking ship. The company will fold in 6 months or less.
Your best bet and most likely outcome will be going at it alone after a significant layoff. The best rep in each major geography will be the only one kept and the territories will become massive. Once you get more drug approvals you will slowly start bringing people back until the company is bought out in 10+ years.
Synergy as a company is not an attractive buy. Sharks will sit on the sidelines and wait for the insane cash burn to send blood into water and then scoop up the drug via chapter 11.
No one will pay any $$ for Synergy now , They know that we don’t have the capital to sustain / grow. Why pay anything now when In the near future they can spend pennies on the dollar...
Synergy was born to be sold. There was never any plan to do anything else. It was a calculated gamble that just went south very quickly. We’ll all be gone very soon in 2018. No one should really be surprised.
yeah our financials aren’t great, mediocre drug, and inexperience in upper management. I don’t see anyone wanting to buy us for the price we want. Sad but true
